Librela Petition Charts
These four charts are included in Exhibit 13(b) of the FDA citizen petition regarding Librela. They summarize individual dogs with death/euthanasia outcomes and time-to-reported-onset patterns in FDA/CVM public quarterly adverse-event data from 2023 Q2–2025 Q4.
Important note:
These charts summarize pharmacovigilance signal counts. They are not incidence rates, relative-risk estimates, or proof of causation.
Click on the chart to view a larger version.
Figure 13-1. All Cases
Individual dogs with death/euthanasia outcomes, including both monotherapy and polytherapy, 2023 Q2–2025 Q4.
Figure 13-2. Monotherapy
Individual dogs with death/euthanasia outcomes where Librela was the only listed drug.
Figure 13-3. All Cases: Time to Onset
Reported time from Librela injection to onset in individual dogs with death/euthanasia outcomes
Figure 13-4. Monotherapy: Time to Onset
Reported time to onset in individual dogs where Librela was the only listed drug
